Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kidney injury biomarkers in multidrug-resistant septic patients treated with colistimethate sodium
TCTR20170330003Recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of colistimethate sodium in sepsis, sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoints: Incidence of subclinical acute kidney injury and Incidence of clinical acute kidney injury. Started Feb 2015; status: recruiting.
02
Drugs
colistimethate sodium
03
Conditions
sepsis
Beyond the preview
Go deeper on TCTR20170330003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170330003.